Three Patients with Symptomatic Cystoid Macular Edema After Cataract Surgery
Abstract
Cystoid Macular Edema (CME) is a known complication of cataract surgery with an estimated incidence of 0.8%, resulting in decreased visual acuity in the post-operative period. While the condition is treatable and the majority of eyes that experience CME are expected to achieve a visual acuity better than 20/40, it is important to identify risk factors for CME and focus on prophylaxis of this post-operative complication. This case series involves a 34-year-old male, an 82-year-old female, and an 83-year-old male. All three patients underwent staged uncomplicated cataract surgeries with a posterior chamber acrylic intraocular lens implant. Each patient had a two-week, or more, interval between cataract surgeries. In the post-operative period, each patient received a standard post-operative drop regimen with a topical antibiotic drop – moxifloxacin – and a steroid eye drop – prednisolone. The moxifloxacin was stopped after 1 week and the prednisolone was tapered over 3 weeks in each eye. All three patients experienced a decrease in visual acuity more than 1 month after cataract surgery and were found to have bilateral CME. All three patients were then treated with topical prednisolone and a nonsteroidal anti-inflammatory eye drop, ketorolac. 3 eyes had resolution of CME and return of good visual acuity less than 1 month after beginning treatment. 1 eye had resolution at 8-week follow-up. Due to a misunderstanding, one patient self-stopped the eye drops for CME and, subsequently, still had CME at a 6 week follow-up. Both ketorolac and prednisolone eye drops were restarted and serial examination is planned. This case series involves evaluating the similarities and differences between three patients with bilateral CME after uncomplicated cataract surgery. Each patient’s clinical course was unique and involved different social factors and levels of compliance with medication.
Start Time
16-4-2025 1:30 PM
End Time
16-4-2025 2:30 PM
Room Number
311
Presentation Type
Oral Presentation
Presentation Subtype
Grad/Comp Orals
Presentation Category
Health
Faculty Mentor
Brent Aebi
Three Patients with Symptomatic Cystoid Macular Edema After Cataract Surgery
311
Cystoid Macular Edema (CME) is a known complication of cataract surgery with an estimated incidence of 0.8%, resulting in decreased visual acuity in the post-operative period. While the condition is treatable and the majority of eyes that experience CME are expected to achieve a visual acuity better than 20/40, it is important to identify risk factors for CME and focus on prophylaxis of this post-operative complication. This case series involves a 34-year-old male, an 82-year-old female, and an 83-year-old male. All three patients underwent staged uncomplicated cataract surgeries with a posterior chamber acrylic intraocular lens implant. Each patient had a two-week, or more, interval between cataract surgeries. In the post-operative period, each patient received a standard post-operative drop regimen with a topical antibiotic drop – moxifloxacin – and a steroid eye drop – prednisolone. The moxifloxacin was stopped after 1 week and the prednisolone was tapered over 3 weeks in each eye. All three patients experienced a decrease in visual acuity more than 1 month after cataract surgery and were found to have bilateral CME. All three patients were then treated with topical prednisolone and a nonsteroidal anti-inflammatory eye drop, ketorolac. 3 eyes had resolution of CME and return of good visual acuity less than 1 month after beginning treatment. 1 eye had resolution at 8-week follow-up. Due to a misunderstanding, one patient self-stopped the eye drops for CME and, subsequently, still had CME at a 6 week follow-up. Both ketorolac and prednisolone eye drops were restarted and serial examination is planned. This case series involves evaluating the similarities and differences between three patients with bilateral CME after uncomplicated cataract surgery. Each patient’s clinical course was unique and involved different social factors and levels of compliance with medication.